Heart Failure Clinics

Papers
(The median citation count of Heart Failure Clinics is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Obesity-Related Heart Failure with Preserved Ejection Fraction37
Hypertrophic Cardiomyopathy in RASopathies33
Exercise-Based Cardiac Rehabilitation Programs in Heart Failure Patients21
Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure19
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease18
Advanced Heart Failure18
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy18
Current Prevalence, Incidence, and Outcomes of Heart Failure with Preserved Ejection Fraction18
Pathophysiology of Heart Failure with Preserved Ejection Fraction16
Left Ventricular Assist Device16
Palliative Care in Patients with Advanced Heart Failure16
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction15
The Risk of Sudden Unexpected Cardiac Death in Children15
Clinical Manifestations of 22q11.2 Deletion Syndrome14
Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis14
Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction14
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia14
Inotropes in Patients with Advanced Heart Failure14
Congestion in Patients with Advanced Heart Failure13
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia12
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis12
Addressing Comorbidities in Heart Failure11
Clinical Practice Guidelines in Cardio-Oncology11
Utilizing Artificial Intelligence to Enhance Health Equity Among Patients with Heart Failure11
Cardiovascular Involvement in mtDNA Disease11
Biomarkers in Heart Failure10
SGLT2 Inhibitors and Safety in Older Patients9
Obesity and Heart Failure with Preserved Ejection Fraction9
Role of Cardiac Rehabilitation After Ventricular Assist Device Implantation9
Pulmonary Embolism9
Mitral and Tricuspid Valves Percutaneous Repair in Patients with Advanced Heart Failure9
Genetics in Congenital Heart Diseases8
Cardiac Magnetic Resonance Quantification of Structure-Function Relationships in Heart Failure8
Renal Dysfunction and Heart Failure with Preserved Ejection Fraction8
Acute Aortic Syndromes8
Spontaneous Coronary Artery Dissection8
Pathophysiology of Advanced Heart Failure8
Role of Cardiac Magnetic Resonance Imaging in Heart Failure7
Anemia and Management of Heart Failure Patients7
Advances in Machine Learning Approaches to Heart Failure with Preserved Ejection Fraction7
Utilizing Conversational Artificial Intelligence, Voice, and Phonocardiography Analytics in Heart Failure Care7
Spectrum of National Institutes of Health-Funded Research in Cardio-Oncology7
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis7
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome6
Advanced Heart Failure in Special Population6
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies6
Advanced Heart Failure in Special Population—Pediatric Age6
SGLT2 Inhibitors in Heart Failure6
Defragmenting Heart Failure Care6
Right Heart Catheterization in Patients with Advanced Heart Failure5
Systematizing Heart Failure Population Health5
Machine Learning in Cardiovascular Imaging5
Cardiac Resynchronization Therapy and Cardiac Contractility Modulation in Patients with Advanced Heart Failure5
Hypertension and Heart Failure with Preserved Ejection Fraction5
Cardiac Mechanoenergetics in Patients with Acute Myocardial Infarction5
Valvular Disease and Heart Failure with Preserved Ejection Fraction5
The Role of Cardiovascular MRI in Cardio-Oncology5
Cardiovascular Magnetic Resonance of Myocardial Fibrosis, Edema, and Infiltrates in Heart Failure5
Assessment of Pericardial Disease with Cardiovascular MRI5
Empowering People Living with Heart Failure4
Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 20194
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction4
SGLT2 Inhibitors and Peripheral Vascular Events4
Acute Decompensated Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction4
Magnetic Resonance-Based Characterization of Myocardial Architecture4
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management4
Myocarditis Following COVID-19 Vaccination4
Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction4
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension4
Clinical Application of Stress Echocardiography in Management of Heart Failure4
Comprehensive Assessment of Heart Failure with Preserved Ejection Fraction Using Cardiac MRI4
The Risk of Sudden Death in Children with Hypertrophic Cardiomyopathy4
Using Artificial Intelligence to Better Predict and Develop Biomarkers4
Cardiac Amyloidosis4
Imaging Cardiovascular Emergencies4
Measuring Myocardial Energetics with Cardiovascular Magnetic Resonance Spectroscopy4
Stage A Heart Failure4
Renoprotective Effects of SGLT2 Inhibitors4
Sleep Disorder and Heart Failure with Preserved Ejection Fraction4
Identification of Patients with Heart Failure in Large Datasets3
Telehealth in Heart Failure3
Cardiac Resynchronization Therapy in Patients with Heart Failure3
Cardiovascular Magnetic Resonance in Right Heart and Pulmonary Circulation Disorders3
Heart Failure with Preserved Ejection Fraction: Current Opinion and Future Perspectives3
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk3
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction3
Struggling Between Liver Transplantation and Portopulmonary Hypertension3
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis3
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity3
Adapting to the Reimbursement Landscape3
The Cardiovascular Manifestations of COVID-193
Cardiovascular Magnetic Resonance in Congenital Heart Disease3
Acute and Chronic Effects of Cancer Drugs on the Cardiovascular System2
Artificial Intelligence and Mechanical Circulatory Support2
Arrhythmic Complications Associated with Cancer Therapies2
Invasive Hemodynamics in Heart Failure with Preserved Ejection Fraction2
Radiation-Induced Cardiac Dysfunction2
Noninvasive Positive Pressure Ventilation for Acute Decompensated Heart Failure2
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors2
Disease-modifier Drugs in Patients with Advanced Heart Failure2
Framework for Digital Health Phenotypes in Heart Failure2
Cardiovascular Magnetic Resonance in Heritable Cardiomyopathies2
Noncoding RNAs in Pulmonary Arterial Hypertension2
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care2
Stress Testing in Heart Failure with Preserved Ejection Fraction2
Acute Decompensated Heart Failure in Patients with Heart Failure with Reduced Ejection Fraction2
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support2
Echocardiography Tips in the Emergency Room2
SGLT2 Inhibitors in Type 2 Diabetes Mellitus2
Management of Common Cardiovascular Emergencies in Critically Ill Patients2
T-cell Immunotherapy and Cardiovascular Disease2
Impact of COVID-19 on Acute Myocardial Infarction Care2
Listing Criteria for Heart Transplant2
Contemporary Management of Acute Decompensated Heart Failure and Cardiogenic Shock2
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction2
Novelties in Therapy of Chronic Heart Failure2
Electronic Health Records and Heart Failure2
When to Use Cardiovascular Magnetic Resonance in Patients with Heart Failure2
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events2
Cardiovascular Imaging in Cardio-Oncology2
Role of New Technologies in Supporting the Treatment of Complex Patients2
Use and Prognostic Implications of Cardiac Troponin in COVID-191
Myocardial Dysfunction in Patients with Cancer1
Digital Transformation in Medicine to Enhance Quality of Life, Longevity, and Health Equity1
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine1
Therapy-Related Clonal Hematopoiesis1
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure1
Asymptomatic Left Ventricular Dysfunction1
Training and Career Development in Cardio-Oncology Translational and Implementation Science1
Sex- and Gender-Related Aspects in Pulmonary Hypertension1
Clinical and Molecular Aspects of Naxos Disease1
Interatrial Shunt Devices1
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice1
Arrythmia-Mediated Valvular Heart Disease1
Sodium-glucose Cotransporter 2 Inhibitors and Nonalcoholic Fatty Liver Disease1
Advanced Heart Failure in a Special Population1
Genetics of High-Altitude Pulmonary Edema1
Transitioning Patients with Heart Failure to Outpatient Care1
Understanding Myocardial Metabolism in the Context of Cardio-Oncology1
Back to Basics1
Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension1
Arrhythmogenic Cardiomyopathy1
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology1
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-191
Oxygen Therapy in Pulmonary Vascular Disease1
Application of 3D Printing Technology in Heart Failure1
Primary Mitral Regurgitation and Heart Failure1
Cardioprotection of High-Risk Individuals1
Heart Failure Clinics1
Pregnancy and Pulmonary Hypertension1
Noninvasive Assessment of Ventricular-Arterial Coupling in Heart Failure1
Tricuspid Regurgitation and Right Heart Failure1
A Review of Heart Failure in Patients with COVID-191
The Influence of Genotype on the Phenotype, Clinical Course, and Risk of Adverse Events in Children with Hypertrophic Cardiomyopathy1
Copyright1
Translational Cardio-Oncology Research to Promote Better Outcomes for One and All1
How to Manage Temporary Mechanical Circulatory Support Devices in the Critical Care Setting1
Role of Cardiovascular Magnetic Resonance in Ischemic Cardiomyopathy1
0.021985054016113